MaxCyte Inc [MXCT] stock prices are up 15.83% to $4.17 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The MXCT shares have gain 14.88% over the last week, with a monthly amount glided 20.52%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
MaxCyte Inc [NASDAQ: MXCT] stock has seen the most recent analyst activity on November 29, 2023, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $7. On August 24, 2021, William Blair initiated with a Outperform rating. Wedbush started tracking the stock assigning a Outperform rating and suggested a price target of $36 on August 24, 2021. Stifel initiated its recommendation with a Buy and recommended $18 as its price target on August 24, 2021. Stephens started tracking with a Overweight rating for this stock on August 24, 2021, and assigned it a price target of $19. In a note dated August 24, 2021, Cowen initiated an Outperform rating.
The stock price of MaxCyte Inc [MXCT] has been fluctuating between $3.16 and $5.55 over the past year. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. MaxCyte Inc [NASDAQ: MXCT] shares were valued at $4.17 at the most recent close of the market. An investor can expect a potential return of 91.85% based on the average MXCT price forecast.
Analyzing the MXCT fundamentals
The MaxCyte Inc [NASDAQ:MXCT] reported sales of 45.60M for trailing twelve months, representing a surge of 1.99%. Gross Profit Margin for this corporation currently stands at 0.79% with Operating Profit Margin at -1.02%, Pretax Profit Margin comes in at -0.78%, and Net Profit Margin reading is -0.78%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.16 and Total Capital is -0.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.76 points at the first support level, and at 3.36 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.46, and for the 2nd resistance point, it is at 4.76.
Ratios To Look Out For
It’s worth pointing out that MaxCyte Inc [NASDAQ:MXCT]’s Current Ratio is 9.81. As well, the Quick Ratio is 9.22, while the Cash Ratio is 2.1. Considering the valuation of this stock, the price to sales ratio is 9.70, the price to book ratio is 2.06.
Transactions by insiders
Recent insider trading involved Erck Stanley C, Director, that happened on Nov 01 ’24 when 47689.0 shares were sold. Director, Johnston John Joseph completed a deal on Oct 28 ’24 to sell 3000.0 shares. Meanwhile, Director Erck Stanley C sold 26082.0 shares on Oct 01 ’24.
